Chlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Chlorothiazide.
Product ID | 0378-0162_4f2271f7-98bc-4b5c-acc6-ad65a717ac84 |
NDC | 0378-0162 |
Product Type | Human Prescription Drug |
Proprietary Name | Chlorothiazide |
Generic Name | Chlorothiazide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1975-07-17 |
Marketing End Date | 2020-12-31 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA084217 |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | CHLOROTHIAZIDE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Marketing Start Date | 1975-07-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA084217 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1975-07-17 |
Marketing End Date | 2020-12-31 |
Marketing Category | ANDA |
Application Number | ANDA084217 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1975-07-17 |
Marketing End Date | 2013-06-06 |
Ingredient | Strength |
---|---|
CHLOROTHIAZIDE | 500 mg/1 |
SPL SET ID: | d652ef6f-2112-43ea-ba01-c3bf4f8d8030 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0143-1209 | Chlorothiazide | Chlorothiazide |
0143-1210 | Chlorothiazide | Chlorothiazide |
0378-0150 | Chlorothiazide | chlorothiazide |
0378-0162 | Chlorothiazide | chlorothiazide |
63323-658 | Chlorothiazide | CHLOROTHIAZIDE SODIUM |
65649-311 | DIURIL | CHLOROTHIAZIDE |